University of North Carolina, Chapel Hill: Lung Diseases trials

The registry lists 14 Lung Diseases studies with University of North Carolina, Chapel Hill as lead sponsor. 0 are open to participants now and 4 have results posted.

Early Phase 1 1Phase 2 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Digihaler in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT05241288Not applicableResults posted
• Assessing Adherence to Home Telemedicine in Individuals With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT04369885Not applicableResults posted
• Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant SuitabilityCompletedNCT01615484Not applicableResults posted
• Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung DiseaseCompletedNCT00934362Phase 2Results posted
• Comparison of 129Xe MRI With 19F MRI in CF Lung DiseaseCompletedNCT03482960Early Phase 1
• Evaluation of Regional Lung Deposition of Inhaled Saline Using the tPAD DeviceCompletedNCT03185650Not applicable
• Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB SubjectsWithdrawnNCT02341183Not applicable
• The Effects of a Self-management Intervention on Low Literacy Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01327456Not applicable
• Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant SuitabilityTerminatedNCT01241942Not applicable
• Molecular Phenotypes for Cystic Fibrosis Lung DiseaseCompletedNCT01116414
• Mucus Dehydration and Evolution of Chronic Obstructive Pulmonary Disease (COPD) Lung DiseaseCompletedNCT00903955
• Long-term Lung Function and Disease Progression in Children With Early Onset Primary Ciliary Dyskinesia Lung DiseaseCompletedNCT00722878
• Gene Modifiers of Cystic Fibrosis Lung DiseaseActive, not recruitingNCT00037765
• Endotoxin and Bronchial Inflammation in AsthmaCompletedNCT00005550